Sort by
Refine Your Search
-
equipment. 4. May review and evaluate the effectiveness of personnel. 5. May plan for and assign personnel to projects under control. 6. Operates with latitude for unreviewed action. 7. May receive general
-
equipment. 4. May review and evaluate the effectiveness of personnel. 5. May plan for and assign personnel to projects under control. 6. Operates with latitude for unreviewed action. 7. May receive general
-
equipment. 4. May review and evaluate the effectiveness of personnel. 5. May plan for and assign personnel to projects under control. 6. Operates with latitude for unreviewed action. 7. May receive general
-
of research equipment. 4. May review and evaluate the effectiveness of personnel. 5. May plan for and assign personnel to projects under control. 6. Operates with latitude for unreviewed action. 7. May receive
-
equipment. 4. May review and evaluate the effectiveness of personnel. 5. May plan for and assign personnel to projects under control. 6. Operates with latitude for unreviewed action. 7. May receive general
-
equipment. 4. May review and evaluate the effectiveness of personnel. 5. May plan for and assign personnel to projects under control. 6. Operates with latitude for unreviewed action. 7. May receive general
-
equipment. 4. May review and evaluate the effectiveness of personnel. 5. May plan for and assign personnel to projects under control. 6. Operates with latitude for unreviewed action. 7. May receive general
-
technical and complex piece of research equipment. 4. May review and evaluate the effectiveness of personnel. 5. May plan for and assign personnel to projects under control. 6. Operates with latitude
-
equipment. 4. May review and evaluate the effectiveness of personnel. 5. May plan for and assign personnel to projects under control. 6. Operates with latitude for unreviewed action. 7. May receive general
-
analyses and murine models. Qualifications • A PhD in Immunology or other fields with deep experience in testing the mechanism of novel immune therapy or immune mechanisms associated with neurodegeneration